What's Going On With eFFECTOR Therapeutics Stock Today?


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


eFFECTOR Therapeutics Inc (NASDAQ:EFTR) is trading higher Monday after Cantor Fitzgerald initiated coverage on the stock.

Cantor Fitzgerald analyst Louise Chen initiated coverage on eFFECTOR Therapeutics with an Overweight rating and announced a price target of $50.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Chen cited the company's underappreciated pipeline as a reason for the rating. She expects pipeline advancements to propel the stock higher. 

The Cantor Fitzgerald analyst listed five upcoming potential catalysts for the stock:

  • The Tomivosertib Phase 2b topline data readout for NSCLC (non-small cell lung cancer) and the 1L extension in combo with pembro in the first half of 2022
  • Zotatifin initial data from Phase 2a expansion cohorts in the first half of 2022.
  • The Tomivosertib Phase 2b topline data readout for NSCLC treatment-naïve patients and the 1L in combo with pembro in the second half of 2022.
  • Zotatifin topline data from Phase 2a expansion cohorts in the second half of 2022.
  • The announcement of additional pipeline advancements into new areas in 2022 and beyond.

eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors

EFTR Price Action: eFFECTOR Therapeutics has traded as high as $34.40 and as low as $26.67 so far today.

The stock was up 1.1% at $26.89 at time of publication. 


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: NewsPrice TargetInitiationSmall CapAnalyst Ratingswhy it's moving